Skip to Content

Organon & Co Ordinary Shares OGN

Morningstar Rating
$20.84 +0.39 (1.91%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

OGN is trading at a 671% premium.
Price
$20.75
Fair Value
$53.30
Uncertainty
Very High
1-Star Price
$89.34
5-Star Price
$67.65
Economic Moat
Fgyhkh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OGN is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$20.45
Day Range
$20.3120.93
52-Week Range
$10.8424.08
Bid/Ask
$20.00 / $22.08
Market Cap
$5.36 Bil
Volume/Avg
3.4 Mil / 1.9 Mil

Key Statistics

Price/Earnings (Normalized)
5.12
Price/Sales
0.84
Dividend Yield (Trailing)
5.37%
Dividend Yield (Forward)
5.37%
Total Yield
5.37%

Company Profile

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women’s health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Small Value
Total Number of Employees
10,000

Comparables

Valuation

Metric
OGN
OPCH
AMPH
Price/Earnings (Normalized)
5.1226.5110.88
Price/Book Value
111.083.432.94
Price/Sales
0.841.143.19
Price/Cash Flow
5.4812.689.38
Price/Earnings
OGN
OPCH
AMPH

Financial Strength

Metric
OGN
OPCH
AMPH
Quick Ratio
0.831.251.68
Current Ratio
1.651.772.18
Interest Coverage
2.288.146.05
Quick Ratio
OGN
OPCH
AMPH

Profitability

Metric
OGN
OPCH
AMPH
Return on Assets (Normalized)
9.70%9.23%14.66%
Return on Equity (Normalized)
20.96%32.66%
Return on Invested Capital (Normalized)
18.19%13.01%19.89%
Return on Assets
OGN
OPCH
AMPH
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Eli Lilly and Co
LLY
DwzmbgvkhdMghg$840.0 Bil
Johnson & Johnson
JNJ
DbtplhxrMywh$358.0 Bil
Merck & Co Inc
MRK
WtbwwhvJym$331.1 Bil
AbbVie Inc
ABBV
RskzpmlhFgmp$300.9 Bil
AstraZeneca PLC ADR
AZN
StzhmjdkbVqqk$244.8 Bil
Roche Holding AG ADR
RHHBY
ZjjdbpjyzHsp$228.8 Bil
Novartis AG ADR
NVS
KmzpbzwlSrpw$215.1 Bil
Amgen Inc
AMGN
MhwbckpgwPfrk$165.3 Bil
Pfizer Inc
PFE
LjqskrdkLplsp$157.2 Bil
Sanofi SA ADR
SNY
PnhvxmdcXgvr$117.4 Bil

Sponsor Center